| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8615521 | Clinical Lymphoma Myeloma and Leukemia | 2018 | 7 Pages |
Abstract
Low EFS and OS rates were found for AML patients in the AYA group. To improve survival rates, intensified chemotherapy regimens and early hematopoietic stem cell transplantation are needed.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
José Carlos Jaime-Pérez, José Ramón Padilla-Medina, LucÃa Teresa Fernández, José Luis Herrera-Garza, César Homero Gutiérrez-Aguirre, Luz TarÃn-Arzaga, David Gómez-Almaguer,